Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001463024 | SCV001666954 | likely benign | Cerebral cavernous malformation 2 | 2020-08-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002540020 | SCV003681992 | uncertain significance | Inborn genetic diseases | 2021-07-14 | criteria provided, single submitter | clinical testing | The c.1238C>T (p.S413L) alteration is located in exon 10 (coding exon 10) of the CCM2 gene. This alteration results from a C to T substitution at nucleotide position 1238, causing the serine (S) at amino acid position 413 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |